Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial
Publication Date
2-14-2023
Content Type
Article
PubMed ID:
Citation
Neuro-Oncology (2022) 25(2):339–350
2-14-2023
Article
Neuro-Oncology (2022) 25(2):339–350